CTOs on the Move

Rimsys Regulatory Management Software

www.rimsys.io

 
Learn about the first and only holistic Regulatory Information Management (RIM) software for medical device companies that consolidates all the functions of regulatory affairs.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.rimsys.io
  • 100, South Commons
    Pittsburgh, PA USA 15212
  • Phone: 855.846.7269

Executives

Name Title Contact Details
Jeff Burk
Chief Technology Officer Profile

Similar Companies

Predictive Oncology

Updates, earnings and commercializationListen to the audio recording of our recent shareholder call where we discussed the latest updates, gave an overview of our earnings report and highlighted the commercialization efforts underway at Predictive Onco...

Medly

Medly Pharmacy is a full-service, digital pharmacy that delivers your prescription medication to you for free, same day, anywhere in New York City and New Jersey. We created a digital experience that makes managing your prescription simple, efficient, and smart for patients and providers.

Kane Biotech

Kane Biotech Inc. is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

emtelligent

Our emtelliPro NLP engine transforms difficult-to-use, narrative medical text into valuable and actionable insights. Enable innovation. Improve competitiveness. Drive performance.

Amolyt Pharma

Amolyt Pharma is building on its team`s established expertise in therapeutic peptides development to deliver life-changing treatments to patients suffering from rare endocrine and metabolic diseases. Amolyt Pharma`s programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism. The collaborative Amolyt Pharma team is well-equipped for upcoming milestones and for the adoption of additional programs as made possible by its global network in the field of endocrinology and with support from a strong syndicate of international investors.